Company Announcement
26 March 2014
At the company's Annual General Meeting today, the following decisions were taken:
- The Annual Report 2013 was adopted
- The Board of Director’s proposal regarding the transfer of profits and losses for 2013 to next year was adopted
- The Board of Directors was re-elected and thus still consists of Karin Garre (Chairman), Allan Andersen and Christian Lundgren
- PricewaterhouseCoopers was re-elected as the company's auditor
- The general meeting authorised the Board of Directors to purchase own shares of up to a total nominal value of DKK 2,455,394 (corresponding to 10% of the company's present share capital) in the period until the next Annual General Meeting
- The proposed fee to the Board of Directors for 2014 was adopted
- The Board of Directors' proposal to adopt electronic communication was adopted.
Karin Garre Allan Andersen
Chairman of the Board of Directors CEO
Contact person:
Allan Andersen, CEO, telephone: +45 4016 3864
About NeuroSearch
NeuroSearch A/S (NEUR) is listed on NASDAQ OMX Copenhagen A/S.
